Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Mallinckrodt
Dow
Moodys
Merck

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NICOTINE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Nicotine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000284 Role of Metabolites in Nicotine Dependence (1) - 1 Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 1995-02-01 The purpose of this study is to determine the effects of cotinine with or without a transdermal nicotine replacement on tobacco withdrawal symptoms.
NCT00000284 Role of Metabolites in Nicotine Dependence (1) - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1995-02-01 The purpose of this study is to determine the effects of cotinine with or without a transdermal nicotine replacement on tobacco withdrawal symptoms.
NCT00000288 Role of Metabolites in Nicotine Dependence (2) - 5 Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 1995-12-01 The purpose of this study is to determine the effects of varying doses of cotinine on cigarette self-administration.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Nicotine

Condition Name

Condition Name for Nicotine
Intervention Trials
Smoking Cessation 172
Nicotine Dependence 113
Smoking 103
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Nicotine
Intervention Trials
Tobacco Use Disorder 253
Schizophrenia 51
Disease 26
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Nicotine

Trials by Country

Trials by Country for Nicotine
Location Trials
United States 808
Canada 48
Sweden 23
France 17
Germany 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Nicotine
Location Trials
California 77
Minnesota 57
Connecticut 55
Pennsylvania 54
Texas 49
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Nicotine

Clinical Trial Phase

Clinical Trial Phase for Nicotine
Clinical Trial Phase Trials
Phase 4 146
Phase 3 77
Phase 2/Phase 3 25
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Nicotine
Clinical Trial Phase Trials
Completed 425
Recruiting 134
Not yet recruiting 88
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Nicotine

Sponsor Name

Sponsor Name for Nicotine
Sponsor Trials
National Institute on Drug Abuse (NIDA) 165
National Cancer Institute (NCI) 54
Yale University 47
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Nicotine
Sponsor Trials
Other 831
NIH 307
Industry 177
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Merck
Boehringer Ingelheim
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.